Curated News
By: NewsRamp Editorial Staff
October 29, 2026
Wolfson Group Expands PhenQ as GLP-1 Use Surges
TLDR
- Wolfson Group expands PhenQ to OneLavi.com, giving U.S. consumers another online channel to access non-prescription weight management products.
- Wolfson Group's PhenQ is a non-prescription weight management brand now sold on Amazon and OneLavi.com, distinct from GLP-1 medications.
- Wolfson Group promotes consumer education and access to non-prescription wellness products, supporting informed weight management choices for better daily health.
- PwC reports 21% of U.S. households had a GLP-1 user by May 2026, highlighting the growing interest in diverse weight management approaches.
Impact - Why it Matters
The rise of GLP-1 medications is reshaping how Americans think about weight management, but it also creates confusion about what non-prescription products can and cannot do. Wolfson Group’s push to expand PhenQ’s availability on Amazon and OneLavi.com, combined with its emphasis on consumer education, highlights a growing need for clear distinctions between wellness supplements and medical treatments. As more households incorporate prescription drugs into their routines, accessible information about complementary lifestyle approaches—nutrition, exercise and non-prescription options—becomes essential for making informed health decisions.
Summary
As Americans explore a growing range of approaches to weight management, Wolfson Group, a Scotland-based international consumer wellness company, is highlighting the role of nutrition, physical activity and non-prescription wellness products in the broader weight management marketplace. According to a June 2026 report from PwC, 21% of U.S. households included a current GLP-1 user as of May 2026, up from 9% in January 2025. While the growing adoption of prescription medications is changing the weight management landscape, consumers continue to encounter a broad range of products, services and lifestyle approaches.
Wolfson Group participates in the non-prescription weight management category through PhenQ, its established consumer wellness brand, which is available to U.S. consumers through Amazon and, more recently, OneLavi.com. The company emphasizes that PhenQ is a non-prescription product and should not be viewed as a substitute for prescribed medical treatments. Wolfson Group is expanding U.S. distribution and recently participated in the ECRM Vitamin, Weight Management & Sports Nutrition Session in Palm Beach Gardens, Florida.
Wolfson Group’s portfolio includes several established wellness brands: PhenQ, TestoPrime, NooCube and YourBiology, spanning weight management, cognitive wellness, gut health and men’s wellbeing. The company continues to invest in consumer education, science-led brand development and expanded U.S. distribution as it builds its presence across the American wellness marketplace.
Source Statement
This curated news summary relied on content distributed by Newsworthy.ai. Read the original source here, Wolfson Group Expands PhenQ as GLP-1 Use Surges
